High Quality Protein for Assisting With Weight Loss

Obesity Clinical Trial

— Egg_breakfast  

Official title:

Does Higher Protein Quality Reduce Energy Intake When Following a Weight Loss Diet Plan? -- Nonpilot, Powered Crossover

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03085511
• Other study ID #: TTU IRB2016-1137
• Status: Completed
• Phase: N/A
• Start date: August 20, 2017
• Est. completion date: May 17, 2019

Study information

• Verified date: May 2019
• Source: Texas Tech University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if, in presence of a reduced calorie diet, a breakfast containing high quality protein source (eggs) would be more effective in reducing hunger and increasing feeling of fullness compared to a breakfast containing a lower quality of protein, but equal energy density. A previous pilot study with the same endpoints yielded borderline significant results; this study has been powered based on that pilot to interrogate our hypotheses.

Description:

This will be a crossover study with 2 experiments. Subjects will follow a reduced energy weight loss diet of 1,200-1,500 kcal adjusted to each individual's body weight for totally 2 weeks in each experiment. They will come to the clinic from day 1 to day 7 and consume egg breakfast (EB) for 5 days under our supervision. Then on weekends during this period they will continue this breakfast at home based on our advice. The next week they will have cereal breakfast (CB) and the process is similar to that in the first week.

The 1st experiment will test the satiety from egg breakfast (EB) and following energy intake in both lunch and dinner, compared with CB (cereal breakfast). Lunch and dinner will be offered on 2 test days during each week. Anthropometric and body composition measurements, blood pressure, blood draw, satiety questionnaire, as well as energy intake will also be collected in the 2 test days and compared between 2 breakfast groups.

The 2nd one is to test whether EB will help in resisting the intake of foods considered tempting, but detrimental to weight loss efforts, compared with CB. The process is similar to experiment 1 except no blood draw, no dinner offered. Instead, a tempting food after lunch will be offered.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: May 17, 2019
• Est. primary completion date: May 17, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 44 Years

Eligibility

Inclusion Criteria:

• Overweight and class I-II obese (BMI 25.0-39.9)

• Sedentary (<3 hours/week of moderate intensity physical activity)

• Otherwise healthy

Exclusion Criteria:

• =5% body weight loss or gain in the three months preceding the study

• Post-menopausal (has not had period for 12 months)

• Plans to begin an exercise program or change current exercise routines between initiation of study and final study

• Anyone following a medical diet prescription

• Anyone with a chronic disease including type II diabetes, hypothyroidism, hypoparathyroidism, cardiovascular disease, cancer of any type

• Health conditions and chronic illness that contraindicate behavioral weight loss treatment using a low calorie diet: Unstable cardiac condition; Polycystic ovary syndrome; Prader-Willi syndrome; Major systemic illness; History of recreational drug abuse or eating disorder (Binge Eating Disorder); Familial hyperlipidemia; Major endocrine diseases (Cushing's syndrome, Grave's disease, Hashimoto's thyroiditis); Gastrointestinal disorder

• Anyone who is currently pregnant, or lactating

• Medications that may influence or inhibit appetite, sensory functioning, or hormone signaling

• Plans to begin taking any supplements that may influence weight loss

• Report of medical condition or surgical intervention that affects swallowing or chewing ability

• Anyone with a pacemaker or other internal medical device

• Any practicing vegans or vegetarians

• Any practicing gluten-free diet

• Allergy, aversion, or dislike to any of the foods offered for meals

Related Conditions & MeSH terms

• Obesity
• Weight Loss

Intervention

Behavioral:
• Egg breakfast (EB)
Breakfast is considered as high quality protein diet, but has similar weight, energy, and macronutrients as the active comparator. The details are as follows: weight 291 g,energy 400 kcal, energy density 1.37 kcal/g, carbohydrate 42.9%, fat 35.6%, protein 19.8%, protein digestibility corrected amino acid score (PDCAAS) 100, leucine 1.77 g, glycemic load 24, fiber 1.0 g.
• Weight Loss Counseling
Weight loss counseling will be administered by a Registered Dietitian and will utilize information and materials derived from the Evidence Analysis Library (EAL) of the Academy of Nutrition and Dietetics (AND). Topics will include portion control, macronutrient distribution, snacking, eating out, cooking and grocery shopping, as well as behavioral strategies including self-monitoring, motivational interviewing, goal setting, and problem solving.
• Weight Loss Diet
Participants will have a 1200-1500kcals diet based on each individual's body weight during the study.
• Cereal Breakfast (CB)
Breakfast is considered as low quality protein diet, but has similar weight, energy, and macronutrients as that in experimental group. The details are as follows: weight 293 g, energy 398 kcal, energy density 1.36 kcal/g, carbohydrate 44.8%, fat 35.4%, protein 19.8%, protein digestibility corrected amino acid score (PDCAAS) 42, leucine 0.48 g, glycemic load 30.8, fiber 4.4 g.

Locations

Country	Name	City	State
United States	Texas Tech University - Department of Nutritional Sciences	Lubbock	Texas

Sponsors (2)

Lead Sponsor	Collaborator
Texas Tech University	American Egg Board

Country where clinical trial is conducted

United States, 

References & Publications (3)

Bayham BE, Greenway FL, Johnson WD, Dhurandhar NV. A randomized trial to manipulate the quality instead of quantity of dietary proteins to influence the markers of satiety. J Diabetes Complications. 2014 Jul-Aug;28(4):547-52. doi: 10.1016/j.jdiacomp.2014.02.002. Epub 2014 Feb 13. — View Citation

Vander Wal JS, Gupta A, Khosla P, Dhurandhar NV. Egg breakfast enhances weight loss. Int J Obes (Lond). 2008 Oct;32(10):1545-51. doi: 10.1038/ijo.2008.130. Epub 2008 Aug 5. — View Citation

Vander Wal JS, Marth JM, Khosla P, Jen KL, Dhurandhar NV. Short-term effect of eggs on satiety in overweight and obese subjects. J Am Coll Nutr. 2005 Dec;24(6):510-5. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change of subjective satiety	This will be measured by questionnaire (VAS) and compared the changes between 2 test days (day 7 and day 14) in experiment 1&2	Change in scores (arbitrary units AUC) from 30 minutes before breakfast consumption to 240 minutes after the consumption on day 7 and day 14
Primary	Change of objective satiety	It is measured by GLP-1. This will be tested in experiment 1 and changes will be compared between 2 test days.	Change in concentration (AUC) from 30 minutes before breakfast consumption to 180 minutes after the consumption on day 7 and day 14
Primary	Change of objective satiety	It is measured by PYY 3-36. This will be tested in experiment 1 and changes will be compared between 2 test days.	Change in concentration (AUC) from 30 minutes before breakfast consumption to 180 minutes after the consumption on day 7 and day 14.
Primary	Change of objective satiety	It is measured by ghrelin. This will be tested in experiment 1 and changes will be compared between 2 test days.	Change in concentration (AUC) from 30 minutes before breakfast consumption to 180 minutes after the consumption on day 7 and day 14.
Primary	Other change of hormone level	It is measured by serum glucose. This will be tested in experiment 1 and changes will be compared between 2 test days.	Change in concentration (AUC) from 30 minutes before breakfast consumption to 180 minutes after the consumption on day 7 and day 14.
Primary	Other change of hormone level	It is measured insulin levels. This will be tested in experiment 1 and changes will be compared between 2 test days.	Change in concentration (AUC) from 30 minutes before breakfast consumption to 180 minutes after the consumption on day 7 and day 14.
Primary	Energy intake (kcal) during ad libitum lunch	Energy intake will be compared between 2 test days in experiment 1	Test day 7 and day 14
Primary	Energy intake (kcal) during ad libitum dinner	Energy intake will be compared between 2 test days in experiment 1	Test day 7 and day 14
Primary	Energy intake (kcal) during ad libitum lunch	Chocolate brownies will be added to the test lunch. Energy intake will be compared between 2 test days in experiment 2	Test day 7 and day 14
Secondary	Change in body weight (kg)	Body weight change from baseline to day 7, and change from day 7 to day 14 will be compared	Day 0, day 7 and day 14
Secondary	Change in waist and hip circumference (cm)	Waist and hip circumference change from baseline to day 7, and change from day 7 to day 14 will be compared	Day 0, day 7 and day 14
Secondary	Change in blood pressure (mm Hg)	BP change from baseline to day 7, and change from day 7 to day 14 will be compared	Day 0, day 7 and day 14
Secondary	Change in fat mass and lean body mass percentage	Body fat change from baseline to day 7, and change from day 7 to day 14 will be compared	Day 0, day 7 and day 14
Secondary	Self report bias in weight, height and body fat percentage	Difference of measurements between self report survey and objective results	Day 0
Secondary	Self report of desire to lose weight and ideal weight		Day 0